Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Symptoms requiring routine medical review: Bloating that persists beyond 46 weeks despite dietary modifications and adequate dose titration Symptoms that significantly impact quality of life or ability to maintain adequate nutrition New or worsening heartburn or regurgitation, which may indicate gastro-oesophageal reflux disease (GORD) Changes in bowel habit such as persistent diarrhoea or constipation Concerns about medication adherence due to gastrointestinal side effects Your healthcare professional may recommend investigations to exclude other causes of bloating, particularly if symptoms are atypical or severe
Jody Dushay, an endocrinologist at Beth Israel Deaconess Medical Center in Boston
Retatrutide (LY3437943): This is a formidable research peptide, a novel agonist for three key receptors: the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors
The area under the curve was determined and normalized to the first timepoint
